Avanzando hacia un Trasplante Hepatico Sostenible

Datos básicos

Código:
2023_1054_1_CHIESI_CARVALHO
Protocolo:
2023_1054_1_CHIESI_CARVALHO
EUDRACT:
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Dotación:
15.000,00 €
Año de incio:
2023
Año de finalización:
2025
PI BIOMÉDICA NACIONAL Finan. Competitiva Privada

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

CHIESI ESPAÑA S.A.

Resultados del Ensayo Clínico


Cytomegalovirus specific polyfunctional t-cells control CMV reactivation, after liver transplantation

Carvalho-Gomes, Angela; (...); Sancho, Victoria Aguilera

Meeting Abstract. 2024


Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries

Li, Elizabeth; (...); NIHR Global Hlth Res Unit Surg

Article. 10.1093/bjs/znad370. 2024


Excess waitlist mortality and survival benefit of liver transplantation for patients with severe acute-on-chronic liver failure: Interim results of the CHANCE study

Gustot, Thierry; (...); Jalan, Rajiv

Meeting Abstract. 2024


External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3-F4 patients.

Carvalho-Gomes Â; (...); Berenguer M

Article. 10.1002/ueg2.12571. 2024


FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis

Martinez-Arenas, Laura; (...); Berenguer, Marina

Meeting Abstract. 2024


FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis

Martinez-Arenas, L.; (...); Berenguer, M.

Meeting Abstract. 2024


FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH.

Martinez-Arenas, Laura; (...); Berenguer, Marina

Article. 10.1111/liv.16085. 2024


Increased cardiovascular risk post-LT in HIV-infected patients? An ELTR based multicenter study

Vinaixa, C.; (...); Aguilera, M. V.

Meeting Abstract. 2024


Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors

Martin-Mateos, R.; (...); Albillos, A.

Meeting Abstract. 2024


Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation

Pilar Ballester, Maria; (...); Nicastro, Emanuele

Meeting Abstract. 2024


Proceedings of the 28th annual congress of the international liver transplantation society.

Shaji Mathew, Johns; (...); Chadha, Ryan

Article. 10.1097/LVT.0000000000000330. 2024


Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Clinical Patterns and Hierarchy of Salvage Treatments

Giuliani, Tommaso; (...); Lopez-Andujar, Rafael

Article. 10.1159/000539460. 2024


The concentration of HDV-RNA correlates with the probability of developing clinical events in patients with chronic hepatitis D

Palom, Adriana; (...); Buti, Maria

Meeting Abstract. 2024


The global prospective observational study to evaluate the role of 'liver transplantation in patients with cirrhosis and severe acute-on-chronic liver failure (CHANCE)': study design, demographics and overall outcome

Gustot, Thierry; (...); Jalan, Rajiv

Meeting Abstract. 2024


Use of HBsAg-positive donors in liver transplantation: an ILTS-EASLAASLD multisociety survey

Vinaixa, C.; (...); Terrault, N.

Meeting Abstract. 2024


Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey.

Vinaixa, Carmen; (...); Berenguer, Marina

Article. 10.1097/LVT.0000000000000432. 2024


Campos de estudio

Compartir